Sector: Pharmaceuticals & Biotechnology

Aurobindo Pharma Share Price

Aurobindo Pharma Ltd.

₹1,217

-6.10(-0.50%)

Invest in AUROPHARMA with up to 4.00x margin.

Trade with MTF

5th Dec 2025 | 3:28 PM

NSE : AUROPHARMA

Open Free Demat Account

Aurobindo Pharma Performance

Price Movement

₹1217.00

₹1209.00

₹1226.40

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹1,226.40

Low₹1,209.00

Open at₹1,225.00

Prev Close₹1,223.10

Volumes3.95 L

Avg Price₹1,218.81

Lower Circuit₹1,100.80

Upper Circuit₹1,345.40

Historical Performance

3M High₹1,249.90

3M Low₹1,033.20

1 Yr High₹1,356.20

1 Yr Low₹1,010.00

3 Yr High₹1,592.00

3 Yr Low₹397.20

5 Yr High₹1,592.00

5 Yr Low₹397.20

Aurobindo Pharma Fundamentals

Market Cap

High in industry

70,718.40 Cr.

PE Ratio (TTM)

Below industry Median

20.70

Dividend Yield

Below industry Median

0.30

Net Profit TTM

4% decr over last year

3,422.48

Net Profit Growth

4% decr over last year

3,422.48

PEG Ratio

Negative PEG TTM

-4.60

ROE

0.4% incr over last year

10.67

Operating Revenue TTM

7.3% incr over last year

32,514.48

Operating Revenue Growth

7.3% incr over last year

32,514.48

Book Value

Below industry Median

2.20

MFI

MFI is mid-range

51.92

RSI

RSI is mid-range

61.03

EPS (TTM)

59.81

Debt to Equity

0.24

Face Value

Operating Profit Margin Qtr.

20.35

Operating Profit Qtr.

1,678.10

Net Profit Qtr.

848.45

Operating Revenue Qtr.

8,285.70

PB Ratio

2.20

Aurobindo Pharma Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024
Total Revenue	2,789.72	2,848.17	2,731.99	2,916.63	2,824.59
Operating Expense	2,065.02	2,051.83	2,135.48	2,203.48	2,103.71
Operating Profit	724.70	796.34	596.51	713.15	720.88
Depreciation	71.49	70.02	93.88	68.28	68.16
Interest	57.45	60	61.09	66.19	51.63
Tax	173.91	190.96	147.35	160.89	186.22
Net Profit	581.37	559.13	408.17	472.05	537.53

AUROPHARMA Stock Recommendation by HDFC

View Call ↗

Research Type

Equity , Long Term

Buy Range

₹1,080 - ₹0

Target Price

₹1,260

Stop Loss

Target Date

23 Aug 26

Potential Returns

16.67 %

View Call ↗

Aurobindo Pharma Technicals

Aurobindo Pharma Ltd. EMA & SMA

₹1217.00

-6.10 (-0.50%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1218.1

Day EMA10 ₹1215.6

Day EMA12 ₹1213.3

Day EMA20 ₹1201

Day EMA26 ₹1191.4

Day EMA50 ₹1163

Day EMA100 ₹1144

Day EMA200 ₹1151.7

Aurobindo Pharma Support and Resistance

Resistance

First Resistance₹1230.23

Second Resistance₹1237.37

Third Resistance₹1247.93

Support

First Support₹1212.53

Second Support₹1201.97

Third Support₹1194.83

Technical Indicators

Day RSI61.03

Day MFI51.92

Day ADX24.80

Day Commodity Channel Index42.80

William-44.44

Day MACD21.91

Day MACD Signal Line25.29

Day ATR24.29

Day ROC1255.49

Day ROC216.44

Aurobindo Pharma Shareholding Pattern

Held By	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Promoter	51.8	51.8	51.8	51.8	51.8	51.8
FII	16.7	16.6	16.3	15.3	14.4	14.2
DII	24.8	25.1	25.2	26.3	26.9	27.6
Public	6.7	6.4	6.7	6.6	6.9	6.4

Aurobindo Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	3.8 L	7.5 L	50.65%
Week	3.32 L	6.54 L	50.78%
1 Month	6.15 L	11.56 L	53.20%
6 Month	6.53 L	13.15 L	49.69%

Aurobindo Pharma SWOT Analysis

Strengths18

Weakness5

Opportunity10

Threats4

Benjamin Graham Value Screen

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Month

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Negative to Positive growth in Sales and Profit with Strong Price momentum

RSI indicating price strength

Stocks Outperforming their Industry Price Change in the Quarter

Aurobindo Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
08 Aug, 2025	4	INTERIM	08 Aug, 2025	Equity Share
20 Feb, 2024	1.5	INTERIM	20 Feb, 2024	Equity Share
20 Nov, 2023	3	INTERIM	20 Nov, 2023	Equity Share
17 Feb, 2023	3	INTERIM	17 Feb, 2023	Equity Share
06 Jun, 2022	4.5	INTERIM	07 Jun, 2022	Equity Share
18 Feb, 2022	1.5	INTERIM	21 Feb, 2022	Equity Share
17 Nov, 2021	1.5	INTERIM	18 Nov, 2021	Equity Share
27 Aug, 2021	1.5	INTERIM	30 Aug, 2021	Equity Share
22 Feb, 2021	1.5	INTERIM	23 Feb, 2021	Equity Share
23 Nov, 2020	1.25	INTERIM	24 Nov, 2020	Equity Share

Aurobindo Pharma Stock Comparison

Financials	Sudeep Pharma Ltd.	Rubicon Research Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.	Patel Chem Specialities Ltd.
Price (₹)	₹666	₹635	₹104.30	₹147.70	₹25	₹83
% Change	-0.48%	1.71%	2.44%	-2.57%	-0.20%	-4.72%
Revenue TTM (₹ Cr)	-	-	₹276.07	-	-	-
Net Profit TTM (₹ Cr)	-	-	₹13.32	-	-	-
PE TTM	-	-	30.10	-	8.60	19.50
1 Year Return	-	31.09	-18.06	63.22	-41.86
ROCE	34.78	34.76	-	-	-	-

Similar Stocks

APL

Asston Pharmaceuticals Ltd.

₹ 90.25

-5.13%

ANTHEM

Anthem Biosciences Ltd.

₹ 655.00

-1.06%

INFLUX

Influx Healthtech Ltd.

₹ 240.00

-0.85%

MEDIORG

Medicamen Organics Ltd.

₹ 26.95

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 659.95

-1.06%

ASTONEALAB

Astonea Labs Ltd.

₹ 150.00

+2.74%

AMWILL

Amwill Health Care Ltd.

₹ 40.75

+1.67%

SENORES

Senores Pharmaceuticals Ltd.

₹ 778.00

-1.08%

SAILIFE

Sai Life Science Ltd.

₹ 874.05

+0.76%

ONESOURCE

OneSource Specialty Pharma Ltd.

₹ 1687.00

+1.15%

SANOFICONR

Sanofi Consumer Healthcare India Ltd.

₹ 4670.00

-0.08%

AKUMS

Akums Drugs & Pharmaceuticals Ltd.

₹ 419.50

-0.19%

EMCURE

Emcure Pharmaceuticals Ltd.

₹ 1398.10

-0.38%

INNOVACAP

Innova Captab Ltd.

₹ 707.00

-0.67%

BLUEJET

Blue Jet Healthcare Ltd

₹ 546.85

-1.43%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 70.60

+9.34%

SHELTER

Shelter Pharma Ltd.

₹ 37.60

-3.34%

CONCORDBIO

Concord Biotech Ltd.

₹ 1409.00

+0.53%

MANKIND

Mankind Pharma Ltd.

₹ 2205.00

-0.06%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 720.50

-0.41%

PPLPHARMA

Piramal Pharma Ltd.

₹ 179.99

-0.48%

TLL

Trident Lifeline Ltd.

₹ 300.00

-1.64%

DPL

Dipna Pharmachem Ltd.

₹ 15.00

-6.19%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.13

-9.20%

FAQ's on AUROPHARMA

What is the current share price of Aurobindo Pharma Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Aurobindo Pharma Ltd. is ₹ 1217 on the NSE and ₹ 1215.35 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Aurobindo Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Aurobindo Pharma Ltd. is approximately ₹ 70718.4 Cr.

What are the PE and PB ratios for Aurobindo Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Aurobindo Pharma Ltd. is 20.7, and the Price-to-Book (PB) ratio is 2.2.

What is the 52-Week High and Low for Aurobindo Pharma Ltd.?

Over the past 52 weeks, the highest price reached by Aurobindo Pharma Ltd. shares was ₹ 1356.2, and the lowest price was ₹ 1010.

What is the current dividend yield for Aurobindo Pharma Ltd.?

As of 6 June 2025, the dividend yield for Aurobindo Pharma Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Aurobindo Pharma Ltd.?

Significant shareholdings in Aurobindo Pharma Ltd. typically include entities such as:

Promoter
Mutual Funds
FII
Other Institutions
Public

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Aurobindo Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Aurobindo Pharma Ltd. is often compared with other major players such as Sudeep Pharma, Rubicon Research, Amanta Healthcare, Anlon Healthcare, Medistep Healthcare and Patel Chem Specialities for analysis and benchmarking.

What is the latest dividend information for Aurobindo Pharma Ltd.?

Aurobindo Pharma Ltd. last declared a INTERIM dividend of ₹ 4 per share for the financial period ending 2025. The record date was set as 2025-08-08, and the payment was/is scheduled around 2025-08-08. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

Open Free Demat Account